Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis

References

• Iyer S, Thankappan K, Balasubramanian D. Early detection of oral cancers. Current status and future prospects. Curr Opin Otolaryngol Head Neck Surg. 2016;24:110–114.
   PubMed Web of Science ®Google Scholar
• Ng JH, Iyer NG, Tan MH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39:297–304.
   PubMed Web of Science ®Google Scholar
• Abdul-Aziz MA, Amin AK, El-Rouby DH, et al. Lymphangiogenesis in oral squamous cell carcinoma: correlation with VEGF-C expression and lymph node metastasis. Int J Dentistry. 2017;2017:7285656.
   PubMed Web of Science ®Google Scholar
• Takes RP, Rinaldo A, Silver CE, et al. Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncol. 2012;48:775–779.
   PubMed Web of Science ®Google Scholar
• Aldridge T, Paraneetharan BP, et al. Epstein-Barr-virus-related mucocutaneous ulceration that mimics oral squamous cell carcinoma: the importance of recognising this new condition. Br J Oral Maxillofac Surg. 2017;55:418–419.
   PubMed Web of Science ®Google Scholar
• Fan K-H, Chen Y-C, Lin C-Y, et al. Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis. Radiat Oncol. 2017;12:184–184.
   PubMed Web of Science ®Google Scholar
• Hosni A, Huang SH, Xu W, et al. Distant metastases following postoperative intensity-modulated radiotherapy for oral cavity squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2017;143:368–375.
   PubMed Web of Science ®Google Scholar
• Wu FY, Tang CY, Guo YM, et al. Transcriptome analysis explores genes related to shikonin biosynthesis in Lithospermeae plants and provides insights into Boraginales’ evolutionary history. Sci Rep. 2017;7:4477.
   PubMed Web of Science ®Google Scholar
• Kourounakis AP, Assimopoulou AN, Papageorgiou VP, et al. Alkannin and shikonin: effect on free radical processes and on inflammation – a preliminary pharmacochemical investigation. Arch Pharm Pharm Med Chem. 2002;335:262–266.
   PubMed Web of Science ®Google Scholar
• Liu T, Xia Y, Li J, et al. Shikonin attenuates concanavalin A-induced acute liver injury in mice via inhibition of the JNK pathway. Mediat Inflamm. 2016;2016:2748367.
   PubMed Web of Science ®Google Scholar
• Xue W, Fan Z, Li Y, et al. Alkannin inhibited hepatic inflammation in diabetic Db/Db mice. Cell Physiol Biochem. 2018;45:2461–2470.
   PubMedGoogle Scholar
• Gao C, Liang C, Nie Z, et al. Alkannin inhibits growth and invasion of glioma cells C6 through IQGAP/mTOR signal pathway. Int J Clin Exp Med. 2015;8:5287–5294.
   PubMed Web of Science ®Google Scholar
• Huu Tung N, Du GJ, Wang CZ, et al. Naphthoquinone components from Alkanna tinctoria (L.) Tausch show significant antiproliferative effects on human colorectal cancer cells. Phytother Res. 2013;27:66–70.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zheng L, Liu J, et al. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Int Immunopharmacol. 2014;21:447–455.
   PubMed Web of Science ®Google Scholar
• Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016;17:719–732.
   PubMed Web of Science ®Google Scholar
• Thind A, Wilson C. Exosomal miRNAs as cancer biomarkers and therapeutic targets. J Extracell Vesicles. 2016;5:31292.
   PubMed Web of Science ®Google Scholar
• Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12:247–256.
   PubMed Web of Science ®Google Scholar
• Sun L, Liu L, Fu H, et al. Association of decreased expression of serum miR-9 with poor prognosis of oral squamous cell carcinoma patients. Med Sci Monit. 2016;22:289–294.
   PubMed Web of Science ®Google Scholar
• Long NK, Kato K, Yamashita T, et al. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncology. 2008;44:1052–1058.
   PubMed Web of Science ®Google Scholar
• Adnan M, Morton G, Hadi S. Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2−ΔΔCt method. Mol Cell Biochem. 2011;357:275–282.
   PubMed Web of Science ®Google Scholar
• Wang YW, Wang SJ, Zhou YN, et al. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. J Cancer Res Clin Oncol. 2012;138:785–797.
   PubMed Web of Science ®Google Scholar
• Ren ZH, Zhang CP, Ji T. Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis. Oncol Lett. 2016;11:1973–1979.
   PubMed Web of Science ®Google Scholar
• Tseng CY, Lin CH, Wu LY, et al. Potential combinational anti-cancer therapy in non-small cell lung cancer with traditional Chinese medicine Sun-Bai-Pi extract and cisplatin. PLOS One. 2016;11:e0155469.
   PubMed Web of Science ®Google Scholar
• Yang JG, Lu R, Ye XJ, et al. Icaritin reduces oral squamous cell carcinoma progression via the inhibition of STAT3 signaling. Int J Mol Sci. 2017;18:132 (1-15).
   Web of Science ®Google Scholar
• Wu T, Cui H, Xu Y, et al. The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro. Onco Targets Ther. 2018;11:3989–4000.
   PubMed Web of Science ®Google Scholar
• Xu P, Li Y, Zhang H, et al. MicroRNA-340 mediates metabolic shift in oral squamous cell carcinoma by targeting glucose transporter-1. J Oral Maxillofac Surg. 2016;74:844–850.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu H. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1. Tumor Biol. 2016;37:4105–4113.
   PubMedGoogle Scholar
• Rather MI, Nagashri MN, Swamy SS, et al. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J Biol Chem. 2013;288:608–618.
   PubMed Web of Science ®Google Scholar
• Chen P, Price C, Li Z, et al. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci USA. 2013;110:11511–11516.
   PubMed Web of Science ®Google Scholar
• Minor J, Wang X, Zhang F, et al. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol. 2012;48:73–78.
   PubMed Web of Science ®Google Scholar
• Xiao C, Wang L, Zhu L, et al. Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression. Biochem Biophys Res Commun. 2014;454:576–580.
   PubMed Web of Science ®Google Scholar
• Kowshik J, Mishra R, Sophia J, et al. Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model. Sci Rep. 2017;7:2045–2045.
   PubMed Web of Science ®Google Scholar
• Kato K, Long NK, Makita H, et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer. 2008;99:647–654.
   PubMed Web of Science ®Google Scholar
• Pramanik KK, Singh AK, Alam M, et al. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer. Tumor Biol. 2016;37:1–12.
   Google Scholar
• Liao J, Xu T, Zheng JX, et al. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway. Int J Mol Med. 2013;32:79–84.
   PubMed Web of Science ®Google Scholar
• Sen M, Pollock NI, Black J, et al. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Neoplasia. 2015;17:256–264.
   PubMed Web of Science ®Google Scholar
• Shah NG, Trivedi TI, Tankshali RA, et al. Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival. Int J Biol Mark. 2006;21:175–183.
   PubMed Web of Science ®Google Scholar
• Klosek SK, Nakashiro K, Hara S, et al. Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma. Oncol Rep. 2008;20:873–878.
   PubMed Web of Science ®Google Scholar
• Zhu L, Shen Y, Sun W. Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma. Biomed Pharmacother. 2017;85:712–717.
   PubMed Web of Science ®Google Scholar
• Li P, Xiao LY, Tan H. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling. Int J Clin Exp Pathol. 2015;8:10365–10374.
   PubMed Web of Science ®Google Scholar